Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Diaceutics PLC

DXRX
Current price
133 GBX 0 GBX (0.00%)
Last closed 132.5 GBX
ISIN GB00BJQTGV64
Sector Healthcare
Industry Diagnostics & Research
Exchange London Exchange
Capitalization 106 201 752 GBX
Yield for 12 month +26.07 %
1Y
3Y
5Y
10Y
15Y
DXRX
21.11.2021 - 28.11.2021

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and the physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom. Address: Building Two, Belfast, United Kingdom, BT9 6GW

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13 149.6 GBX

P/E ratio

Dividend Yield

Current Year

+2 355 683 801 GBX

Last Year

+1 938 700 277 GBX

Current Quarter

+1 369 236 852 GBX

Last Quarter

+986 446 950 GBX

Current Year

+1 515 553 913 GBX

Last Year

+1 395 279 682 GBX

Current Quarter

+827 108 548 GBX

Last Quarter

+688 445 365 GBX

Key Figures DXRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 101 371 GBX
Operating Margin TTM -6.19 %
PE Ratio
Return On Assets TTM -3.99 %
PEG Ratio
Return On Equity TTM -4.19 %
Wall Street Target Price 13 149.6 GBX
Revenue TTM 23 556 838 GBX
Book Value 0.48 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 15 %
Dividend Yield
Gross Profit TTM 16 640 577 GBX
Earnings per share -0.02 GBX
Diluted Eps TTM -0.02 GBX
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 61.2 %
Profit Margin -7.37 %

Dividend Analytics DXRX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DXRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation DXRX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 101.0101
Enterprise Value Revenue 3.8559
Price Sales TTM 4.5083
Enterprise Value EBITDA 38.0594
Price Book MRQ 2.6196

Financials DXRX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DXRX

For 52 weeks

81.51 GBX 135.18 GBX
50 Day MA 127.83 GBX
Shares Short Prior Month
200 Day MA 109.61 GBX
Short Ratio
Shares Short
Short Percent